ReviewCancer treatment reviews2022

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.

Yu Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.